Proteomic profiling of differential display analysis for human oral squamous cell carcinoma: 14-3-3 σ Protein is upregulated in human oral squamous cell carcinoma and dependent on the differentiation level

Proteomics - Clinical Applications

Volumn 3, Issue 11, 2009, Pages 1338-1347

  Hayashi, Eiko ^a   Kuramitsu, Yasuhiro ^a   Fujimoto, Masanori ^a   Zhang, Xiulian ^a   Tanaka, Toshiyuki ^a   Uchida, Kenichiro ^a   Fukuda, Teruyo ^a   Furumoto, Hiroko ^a   Ueyama, Yoshiya ^a   Nakamura, Kazuyuki ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

14 3 3 ; 2 D PAGE; Biomarker; Oral squamous cell carcinoma

Indexed keywords

BIOLOGICAL MARKER; CYCLINE; INITIATION FACTOR 3; ISOCITRATE DEHYDROGENASE; MITOCHONDRIAL PROTEIN; PROTEASOME; PROTEIN 14 3 3; PROTEIN SUBUNIT; PROTEOME; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOUTH CARCINOMA; MOUTH FLORA; MOUTH TUMOR; NUCLEOTIDE SEQUENCE; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR; TUMOR DIFFERENTIATION; UPREGULATION;

EUKARYOTA;

EID: 77951071245     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900091     Document Type: Article

References (50)

1. Gupta, P. C., Pindborg, J. J., Mehta, F. S., Comparison of carcinogenicity of betel quid with and without tobacco: an epidemiologic review. Ecol. Dis. 1982, 1, 213-219.
2. Moore, S. R., Johnson, N. W., Pierce, A. M., Wilson, D. F., Oral oncology: the epidemiology of mouth cancer: a review of global incidence. Oral Dis. 2000, 6, 65-74.
3. Froehlich, M., Epidemiologie der Lippenund Mundschleim haut karzinome. Med Aktuell. 1991, 17, 180-181.
4. McDowell, J. D., An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol. Clin. North Am. 2006, 39, 277-294.
5. Franceschi, S., Bidoli, E., Herrero, R., Munoz, N., Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Eur. J. Cancer (Oral. Oncol.). 2000, 3, 106-115.
6. Lingen, M. W., Chang, K. W., McMurray, S. J., Solt, D. B. et al., Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck 2000, 22, 328-335.
7. He, Q. Y., Chen, J., Kung, H. F., Yuen, A. P., Chiu, J. F., Identification of tumor-associated proteins in oral tongue squamouse cell carcinoma by proteomics. Proteomics 2004, 4, 271-278.
8. Chen, J., He, Q. Y., Yuen, A. P., Chiu, J. F., Proteomics of buccal squamouse cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 2004, 4, 2465-2475.
9. Jain, M. R., Liu, T., Hu, J., Darfler, M. et al., Quantitative proteomic analysis of formalin fixed paraffin embedded oral HPV lesions from HIV patients. Open Proteomics J. 2008, 1, 40-45.
10. Hiratsuka, H., Miyakawa, A., Nakamori, K., Kido, Y. et al., Multivariate analysis of occult lymph node metastasis as a prognostic indication for patients with squamous cell carcinoma. Cancer 1997, 80, 351-356.
11. Kohama, G., Surgical management of carcinoma of the tongue and floor of the mouth with special reference to clinical stage and histological grade. Oral Oncol. 1995, 2, 242-245.
12. Hemmer, J., Thein, T., van Heerden, W. F.P., The value of DNA flow cytometry in predicting the development of lymph node metastasis and survival in patients with locally recurrent oral squamous cell carcinoma. Cancer 1997, 79, 2309-2313.
13. Asakage, T., Yokose, T., Mukai, K., Tsugane, S. et al., Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue. Cancer 1998, 82, 1443-1448.
14. Schena, M., Shalon, D., Davis, R. W., Brown, P. O., Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270, 467-470.
15. DeRisi, J., Penland, L., Brown, P. O., Bittner, M. L. et al., Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 1996, 14, 457-460.
16. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C. et al., Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286, 531-537.
17. Brazma, A., Vilo, J., Gene expression data analysis. FEBS Lett. 2000, 480, 17-24.
18. Eisen, M. B., Spellman, P. T., Brown, P. O., Botstein, D., Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 1998, 95, 14863-14868.
19. Mendez, E., Cheng, C., Farwell, D. G., Ricks, S. et al., Transcriptional expression profiles of oral squamous cell carcinomas. Cancer 2002, 95, 1482-1494.
20. Ibrahim, S. O., Aarsaether, N., Holsve, M. K., Kross, K. W. et al., Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs Norway. Oral Oncol. 2003, 39, 37-48.
21. O'Farrell, P. H., High-resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975, 250, 4007-4021.
22. Celis, J. E., Bravo, R., Two-Dimensional Gel Electrophoresis of Protein: Methods and Applications, Academic Press, London 1984.
23. Dunn, M. J., Radola, B. J., in: Charambach, A., Dunn, M. J., Radola, D. J. (Eds.), Advances in Electrophoresis. Two-Dimensional Polyacrylamide Gel Electrophoresis, VHC, New York 1987, 1, 1-110.
24. Latner, A. L., Marshall, T., Gambie, M., Microheterogeneity of serum myeloma immunoglobulins revealed by a technique of high-resolution two-dimensional electrophoresis. Electrophoresis 1980, 1, 82-89.
25. Nakamura, K., Fujimoto, M., Tanaka, T., Fujikura, Y., Differential expression of nucleophosmin and stathmin in human T lymphoblastic cell lines, CCRF-CEM and JURKAT analyzed by two-dimensional gel electrophoresis. Electrophoresis 1995, 16, 1530-1535.
26. Fujimoto, M., Nagasaka, Y., Tanaka, T., Nakamura, K., Analysis of heat shock-induced monophosphorylation of stathmin in human T lymphoblastic cell line JURKAT by two-dimensional gel electrophoresis. Electrophoresis 1998, 19, 2515-2520.
27. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J., Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
28. Liu, Y., Chen, Q., Zhang, J. T., Tumor suppressor gene 14-3-3sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in nonsmall cell lung cancers as identified by proteomic profiling. J. Proteome Res. 2004, 3, 728-735.
29. Li, C., Tan, Y. X., Zhou, H., Ding, S. J. et al., Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: identification of potential tumor markers. Proteomics 2005, 5, 1125-1139.
30. Yaffe, M. B., How do 14-3-3 sigma proteins work? - Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 2002, 513, 53-57.
31. Peng, C. Y., Graves, P. R., Wu, Z ., Shaw, A. S., Piwnica-Worms, H., Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serin-216. Science 1997, 277, 1501-1505.
32. Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K. et al., High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer. Proc. Natl. Acad. Sci. USA 2000, 97, 6049-6054.
33. Mhawech, P., Benz, A., Cerato, C., Greloz, V. et al., Downregulation of 14-3-3 σ in ovary, prostate and endometrial carcinomas is associated with CpG island methylation. Mod. Pathol. 2005, 18, 340-348.
34. Lodygin, D., Diebold, J., Hermeking, H., Prostate cancer is characterized by epigenetic silencing of 14-3-3 σ expression. Oncogene 2004, 23, 9034-9041.
35. Lodygin, D., Yazdi, A. S., Sander, C. A., Herzinger, T., Hermeking, H., Analysis of 14-3-3 σ expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene 2003, 22, 5519-5524.
36. Osada, H., Tatematsu, Y., Yatabe, Y., Nakagawa, T. et al., Frequent and histological type-specific inactivation of 14-3-3 σ in human lung cancers. Oncogene 2002, 21, 2418-2424.
37. Iwata, N., Yamamoto, H., Sasaki, S., Itoh, F. et al., Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma. Oncogene 2000, 19, 5298-5302.
38. Vellucci, V. F., Germino, F. J., Reiss, M., Cloning of putative regulatory genes from primary human keratinocytes by substractive hybridization. Gene 1995, 166, 213-220.
39. Gasco, M., Bell, A. K., Heath, V., Sullivan, A. et al., Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Cancer Res. 2002, 62, 2072-2076.
40. Bhawal, U. K., Tsukinoki, K., Sasahira, T., Sato, F. et al., Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer. Oncol. Rep. 2007, 18, 817-824.
41. Bhawal, U. K., Sugiyama, M., Nomura, Y., Kuniyasu, H., Tsukinoki, K., Loss of 14-3-3 sigma protein expression and presence of human papillomavirus type 16 E6 in oral squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 2008, 134, 1055-1059.
42. Gasco, M., Sullivan, A., Repellin, C., Brooks, L. et al., Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia. Oncogene 2002, 21, 1876-1881.
43. Qi, W., Liu, X., Qiao, D., Martinez, J. D., Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int. J. Cancer. 2005, 113, 359-363.
44. Villaret, D. B., Wang, T., Dillon, D., Xu, J. et al., Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 2000, 110, 374-381.
45. Fernández-Irigoyen, J., Santamaracute, A E., Sesma, L., Munñoz, J. et al., Oxidation of specific methionine and tryptophan residues of apolipoprotein A-I in hepatocarcinogenesis. Proteomics 2005, 5, 4964-4972.
46. Levine, R. L., Moskovitz, J., Stadtman, E. R., Oxidation of methionine in proteins: roles in antioxidant defense and cellular regulation. IUBMB Life 2000, 50, 301-307.
47. Benzinger, A., Muster, N., Koch, H. B., Yates, J. R., III, Hermeking, H., Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Mol. Cell. Proteomics. 2005, 4, 785-795.
48. Coux, O., Tanaka, K., Goldberg, A. L., Structure and functions of the 20S and 26S proteasomes. Ann. Rev. Biochem. 1996, 65, 801-847.
49. Chung, S., Kim, M., Choi, W., Chung, J., Lee, K., Expression of translationally controlled tumor protein mRNA in human colon cancer. Cancer Lett. 2000, 156, 185-190.
50. Lin, L., Holbro, T., Alonsco, G., Gerosa, D., Burger, M. M., Molecular interaction between human tumor marker protein p150, the largest subunit of eIF3, and intermediate filament protein K7. J. Cell. Biochem. 2001, 80, 483-490.